In this week's summary of ratings views: Uncertain tariff policies pose significant market and economic risks. The corporate outlook is fundamentally healthy, but tariffs top the worry list. We believe global bond issuance will increase 3% and markets will have sufficient capacity to absorb refinancing needs in 2025. Also: implications of DeepSeek's release, and the credit outlook for global pharmaceuticals.